-
2
-
-
84859590655
-
Clinical evidence for the regression of liver fibrosis
-
E.L. Ellis, and D.A. Mann Clinical evidence for the regression of liver fibrosis J Hepatol 56 2012 1171 1180
-
(2012)
J Hepatol
, vol.56
, pp. 1171-1180
-
-
Ellis, E.L.1
Mann, D.A.2
-
3
-
-
84896707511
-
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice
-
C. Baeck, X. Wei, M. Bartneck, V. Fech, F. Heymann, N. Gassler, and et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice Hepatology 59 2014 1060 1072
-
(2014)
Hepatology
, vol.59
, pp. 1060-1072
-
-
Baeck, C.1
Wei, X.2
Bartneck, M.3
Fech, V.4
Heymann, F.5
Gassler, N.6
-
4
-
-
84919465499
-
Cell death and cell death responses in liver disease: Mechanisms and clinical relevance
-
e764
-
T. Luedde, N. Kaplowitz, and R.F. Schwabe Cell death and cell death responses in liver disease: mechanisms and clinical relevance Gastroenterology 147 2014 765 783 e764
-
(2014)
Gastroenterology
, vol.147
, pp. 765-783
-
-
Luedde, T.1
Kaplowitz, N.2
Schwabe, R.F.3
-
5
-
-
84906535982
-
Roles for chemokines in liver disease
-
e571
-
F. Marra, and F. Tacke Roles for chemokines in liver disease Gastroenterology 147 2014 577 594 e571
-
(2014)
Gastroenterology
, vol.147
, pp. 577-594
-
-
Marra, F.1
Tacke, F.2
-
6
-
-
84869208905
-
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
-
P. Ramachandran, A. Pellicoro, M.A. Vernon, L. Boulter, R.L. Aucott, A. Ali, and et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc Natl Acad Sci U S A 109 2012 E3186 E3195
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. E3186-E3195
-
-
Ramachandran, P.1
Pellicoro, A.2
Vernon, M.A.3
Boulter, L.4
Aucott, R.L.5
Ali, A.6
-
7
-
-
84155175629
-
Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression
-
J. Jiao, D. Sastre, M.I. Fiel, U.E. Lee, Z. Ghiassi-Nejad, F. Ginhoux, and et al. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression Hepatology 55 2012 244 255
-
(2012)
Hepatology
, vol.55
, pp. 244-255
-
-
Jiao, J.1
Sastre, D.2
Fiel, M.I.3
Lee, U.E.4
Ghiassi-Nejad, Z.5
Ginhoux, F.6
-
8
-
-
84876114251
-
Natural killer cells in liver disease
-
Z. Tian, Y. Chen, and B. Gao Natural killer cells in liver disease Hepatology 57 2013 1654 1662
-
(2013)
Hepatology
, vol.57
, pp. 1654-1662
-
-
Tian, Z.1
Chen, Y.2
Gao, B.3
-
9
-
-
84893650001
-
Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis
-
L. Hammerich, J.M. Bangen, O. Govaere, H.W. Zimmermann, N. Gassler, S. Huss, and et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis Hepatology 59 2014 630 642
-
(2014)
Hepatology
, vol.59
, pp. 630-642
-
-
Hammerich, L.1
Bangen, J.M.2
Govaere, O.3
Zimmermann, H.W.4
Gassler, N.5
Huss, S.6
-
10
-
-
84894072682
-
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
-
J. Ehling, M. Bartneck, X. Wei, F. Gremse, V. Fech, D. Mockel, and et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis Gut 63 2014 1960 1971
-
(2014)
Gut
, vol.63
, pp. 1960-1971
-
-
Ehling, J.1
Bartneck, M.2
Wei, X.3
Gremse, F.4
Fech, V.5
Mockel, D.6
-
11
-
-
84929606405
-
Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis
-
C. Kantari-Mimoun, M. Castells, R. Klose, A.K. Meinecke, U.J. Lemberger, P.E. Rautou, and et al. Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis Hepatology 61 6 2015 2042 2055
-
(2015)
Hepatology
, vol.61
, Issue.6
, pp. 2042-2055
-
-
Kantari-Mimoun, C.1
Castells, M.2
Klose, R.3
Meinecke, A.K.4
Lemberger, U.J.5
Rautou, P.E.6
-
12
-
-
84898987733
-
Vascular endothelial growth factor promotes fibrosis resolution and repair in mice
-
e1331
-
L. Yang, J. Kwon, Y. Popov, G.B. Gajdos, T. Ordog, R.A. Brekken, and et al. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice Gastroenterology 146 2014 1339 1350 e1331
-
(2014)
Gastroenterology
, vol.146
, pp. 1339-1350
-
-
Yang, L.1
Kwon, J.2
Popov, Y.3
Gajdos, G.B.4
Ordog, T.5
Brekken, R.A.6
-
13
-
-
84928898387
-
Pathobiology of liver fibrosis: A translational success story
-
Y.A. Lee, M.C. Wallace, and S.L. Friedman Pathobiology of liver fibrosis: a translational success story Gut 64 5 2015 830 841
-
(2015)
Gut
, vol.64
, Issue.5
, pp. 830-841
-
-
Lee, Y.A.1
Wallace, M.C.2
Friedman, S.L.3
-
14
-
-
49749145668
-
Senescence of activated stellate cells limits liver fibrosis
-
V. Krizhanovsky, M. Yon, R.A. Dickins, S. Hearn, J. Simon, C. Miething, and et al. Senescence of activated stellate cells limits liver fibrosis Cell 134 2008 657 667
-
(2008)
Cell
, vol.134
, pp. 657-667
-
-
Krizhanovsky, V.1
Yon, M.2
Dickins, R.A.3
Hearn, S.4
Simon, J.5
Miething, C.6
-
15
-
-
0032146551
-
Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
-
J.P. Iredale, R.C. Benyon, J. Pickering, M. McCullen, M. Northrop, S. Pawley, and et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 102 1998 538 549
-
(1998)
J Clin Invest
, vol.102
, pp. 538-549
-
-
Iredale, J.P.1
Benyon, R.C.2
Pickering, J.3
McCullen, M.4
Northrop, M.5
Pawley, S.6
-
16
-
-
84862195154
-
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
-
T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, C. Benner, and et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc Natl Acad Sci U S A 109 2012 9448 9453
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 9448-9453
-
-
Kisseleva, T.1
Cong, M.2
Paik, Y.3
Scholten, D.4
Jiang, C.5
Benner, C.6
-
17
-
-
84866692545
-
Deactivation of hepatic stellate cells during liver fibrosis resolution in mice
-
e1022
-
J.S. Troeger, I. Mederacke, G.Y. Gwak, D.H. Dapito, X. Mu, C.C. Hsu, and et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice Gastroenterology 143 2012 1073 1083 e1022
-
(2012)
Gastroenterology
, vol.143
, pp. 1073-1083
-
-
Troeger, J.S.1
Mederacke, I.2
Gwak, G.Y.3
Dapito, D.H.4
Mu, X.5
Hsu, C.C.6
-
18
-
-
84877066766
-
Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
-
J.P. Iredale, A. Thompson, and N.C. Henderson Extracellular matrix degradation in liver fibrosis: biochemistry and regulation Biochim Biophys Acta 1832 2013 876 883
-
(2013)
Biochim Biophys Acta
, vol.1832
, pp. 876-883
-
-
Iredale, J.P.1
Thompson, A.2
Henderson, N.C.3
-
19
-
-
84877141184
-
Evolving therapies for liver fibrosis
-
D. Schuppan, and Y.O. Kim Evolving therapies for liver fibrosis J Clin Invest 123 2013 1887 1901
-
(2013)
J Clin Invest
, vol.123
, pp. 1887-1901
-
-
Schuppan, D.1
Kim, Y.O.2
|